Hims & Hers Health (HIMS) Cash from Investing Activities (QoQ) (2019 - 2026)
Hims & Hers Health (HIMS) Cash from Investing Activities (QoQ) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 88.07 Bn | 86.20 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.75 Bn | 32.01 Bn | 1.97 Bn |
| 3 | Zoetis | 31.84 Bn | 29.90 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.18 Bn | 23.12 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.09 Bn | 20.93 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.32 Bn | 21.32 Bn | - |
| 7 | Viatris | 19.96 Bn | 18.16 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.66 Bn | 16.34 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.44 Bn | 12.02 Bn | 785.00 Mn |
| 10 | Hims & Hers Health | 6.44 Bn | 5.69 Bn | 396.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 81.54% |
| Dec 31, 2025 | 90.57% |
| Sep 30, 2025 | -4,108.07% |
| Jun 30, 2025 | 35.70% |
| Mar 31, 2025 | -90.61% |
| Dec 31, 2024 | -65.22% |
| Sep 30, 2024 | -132.98% |
| Jun 30, 2024 | -134.27% |
| Mar 31, 2024 | -36.98% |
| Dec 31, 2023 | 166.63% |
| Sep 30, 2023 | -1,408.93% |
| Jun 30, 2023 | 157.70% |
| Mar 31, 2023 | -168.52% |
| Dec 31, 2022 | 333.04% |
| Sep 30, 2022 | -120.10% |
| Jun 30, 2022 | -30.53% |
| Mar 31, 2022 | 80.17% |
| Dec 31, 2021 | 139.51% |
| Sep 30, 2021 | -214.01% |
| Jun 30, 2021 | 113.92% |